M1329 Pts act pvd 2 wks 8 wks
M-Codes
Also known as: active proliferative retinopathy, PVD active, neovascularization
Patients with active proliferative retinopathy in the 2 weeks to 8 weeks timeframe. Documents patients with advanced retinal disease requiring intensive monitoring.
Clinical Context
Retinal disease quality measure tracking patients with active neovascularization and proliferative changes requiring frequent monitoring and treatment.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.